Prime Minister Narendra Modi to interact with three teams involved in the development of COVID-19
New Delhi:
Prime Minister Narendra Modi will interact with three teams involved in COVID-19 vaccine development via video conference on Monday. The Prime Minister’s Office tweeted today that the three teams are from Gennova Biopharma, Biological E, and Dr Reddy’s.
“Tomorrow, November 30, 2020, PM @narendramodi will interact, via videoconference, with three teams that are involved in the development of a COVID-19 vaccine. The teams with which they will interact are Gennova Biopharma, Biological E and Dr Reddy’s, “it read.
Tomorrow, November 30, 2020, afternoon @Narendra Modi will interact, via videoconference, with three teams that are involved in the development of a COVID-19 vaccine. The teams he will interact with are Gennova Biopharma, Biological E and Dr. Reddy’s.
– PMO India (@PMOIndia) November 29, 2020
Prime Minister Modi visited Ahmedabad, Hyderabad and Pune on Saturday to review the development and manufacturing process of coronavirus vaccines at facilities in these cities.
Prime Minister Modi visited the Serum Institute of India (SII) in Pune on Saturday in the last leg of his three-city visit to check on how Indian companies are working on vaccines for coronavirus infection.
Your visit to Ahmedabad and then to Hyderabad has started. He began by visiting the manufacturing facilities of the Zydus Cadila pharmaceutical company, near Ahmedabad. He then proceeded to the Bharat Biotech facility in Hyderabad before arriving in Pune.
“We discussed the vaccine implementation plan with Prime Minister Modi during his visit,” SII Executive Director Adar Poonawalla told reporters in an online briefing on Covishield on Saturday.
“We are in awe of what he (PM Modi) already knew. He was impressed with the new facility we have built. The new facility can handle more than 1 billion doses,” said the CEO of the Serum Institute.
Earlier this week, the Serum Institute of India said it will sell the Oxford COVID-19 vaccine to the government for Rs 250 and to pharmacies for Rs 1,000 per dose.
A minimum of 100 million doses will be available in January and hundreds of millions could be ready by the end of February, Poonawalla told NDTV.
He said they are “waiting for the vaccine to be available as quickly as possible.” “It will be in the hands of the regulators in a couple of weeks,” Poonawalla had said. His company has an agreement with the government to mass manufacture doses of the Covid vaccine.
.
